Revolax Sub-Q Lidocaine
$29.50
Revolax Sub-Q Lidocaine is a KFDA-certified monophasic dermal filler containing 24 mg/mL high-purity hyaluronic acid (98.7% purity) and 0.3% lidocaine. Engineered with triple cross-linking technology, it delivers 8-12 month longevity for facial contouring and wrinkle correction while reducing injection pain by 78% – clinically proven 93% patient satisfaction in volume restoration.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $28.32 |
| 16-30 | 6% | $27.73 |
| 31-Unlimited | 8% | $27.14 |
Revolax Sub-Q Lidocaine Dermal Filler
Premium Monophasic HA Filler with Integrated Anesthetic
Medical Grade Formulation
KFDA-certified dermal filler containing 24 mg/mL high-purity hyaluronic acid with integrated 0.3% lidocaine. Features optimized 3D molecular structure providing 1.2 million mPa·s viscosity for structural support. Clinically proven 93% patient satisfaction in volume restoration with 8-12 month persistence. Reduces injection pain by 78% compared to non-anesthetic formulas.
Clinical Advantages
Pain Reduction
Integrated 0.3% lidocaine reduces discomfort by 78% during administration
High Purity
98.7% non-animal stabilized HA with ultra-low endotoxins (<0.05 EU/mg)
Structural Support
1.2 million mPa·s viscosity for optimal volume in deep tissue
Longevity
8-12 month duration through advanced cross-linking technology
Advanced Technology
Molecular Optimization
- Monophasic gel structure
- Triple cross-linking technology
- Optimized 3D molecular configuration
Performance Metrics
- Viscosity: 1,200,000 mPa·s
- G prime: Optimal for deep support
- Swelling rate: <2% reported cases
Packaging Specifications
Storage: 2-25°C in original packaging
Shelf Life: 24 months from manufacture
Do Not: Freeze or expose to sunlight
Disposal: Single-use only
Clinical Protocol
Injection Parameters
- Needle: 25G-27G cannula
- Depth: SubQ/Supraperiosteal
- Max per session: 2.0mL
Indications
- Facial contouring
- Deep wrinkle correction
- Lip augmentation
Post-Care
- Cold compress application
- No pressure for 72hrs
- Follow-up at 2-4 weeks
Contraindications
Avoid in pregnancy, active inflammation, hypersensitivity to gram-positive bacteria, bleeding disorders, or active skin infections.
Medical Use Only
* Individual results may vary based on metabolic factors and injection technique. This product is for licensed practitioners only. Manufactured by Across Co. Ltd. (GMP 4103), Busan, South Korea. Certifications: KFDA 15-542, CE 0481, ISO 13485:2016. Report adverse events to local health authorities. Our company bears no responsibility for off-label use.

Reviews
There are no reviews yet.